“We chose to partner with ESM Technologies because NEM represents a unique, safe and scientifically substantiated technology that fits a key target health platform for us, joint and bone health,” said Jeremy Moore, director of marketing for Stratum Nutrition. “We evaluated several other technologies in the joint health category, but chose NEM because we feel it has the best potential to become the next dominant joint health ingredient.”
Some of the criteria Moore cited as important factors in choosing to invest in NEM over other joint health ingredients are its small daily dose size (500mg), a robust yet safe supply chain, and clinically proven results in osteoarthritic patients within 7-10 days. The ingredient also fits well with the sustainability efforts of Novus.
“By using a portion of the egg that has historically been discarded by suppliers of liquid eggs (the shell and membrane), we’re reducing the amount of these materials that would normally go to waste and be sent to either a landfill or spread on fields,” said Micah Osborne, president of ESM Technologies.
Through this technology partnership, Novus will infuse sales, marketing and R&D resources to further advance the science behind NEM as well as the global sales and marketing of the product.
© FoodBev Media Ltd 2020
World Dairy Innovation Awards – OPEN FOR EARLY BIRD ENTRIES!
The awards celebrate excellence and innovation across the global dairy industry.
Don’t miss out on having your innovations recognised on a global scale.
Early bird deadline 19 March – enter now!